Predictive Oncology Inc.
POAI
$0.9994
$0.00940.95%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 110.30K | 611.60K | 345.70K | 278.70K | 4.90K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 110.30K | 611.60K | 345.70K | 278.70K | 4.90K |
| Cost of Revenue | 45.10K | 290.60K | 196.90K | 153.00K | 22.40K |
| Gross Profit | 65.20K | 321.00K | 148.80K | 125.80K | -17.60K |
| SG&A Expenses | 2.35M | 2.44M | 2.46M | 3.32M | 3.56M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.40M | 2.74M | 2.66M | 3.47M | 3.59M |
| Operating Income | -2.29M | -2.12M | -2.31M | -3.19M | -3.58M |
| Income Before Tax | -2.29M | -2.10M | -2.28M | -3.18M | -3.56M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -2.29M | -2.10M | -2.28M | -3.18M | -3.56M |
| Earnings from Discontinued Operations | -157.50K | -68.70K | -811.30K | -- | -654.70K |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.44M | -2.17M | -3.09M | -3.18M | -4.22M |
| EBIT | -2.29M | -2.12M | -2.31M | -3.19M | -3.58M |
| EBITDA | -2.25M | -2.08M | -2.27M | -3.03M | -3.55M |
| EPS Basic | -0.34 | -0.33 | -0.48 | -0.68 | -1.04 |
| Normalized Basic EPS | -0.20 | -0.20 | -0.22 | -0.43 | -0.55 |
| EPS Diluted | -0.34 | -0.33 | -0.48 | -0.68 | -1.04 |
| Normalized Diluted EPS | -0.20 | -0.20 | -0.22 | -0.43 | -0.55 |
| Average Basic Shares Outstanding | 7.15M | 6.68M | 6.40M | 4.66M | 4.06M |
| Average Diluted Shares Outstanding | 7.15M | 6.68M | 6.40M | 4.66M | 4.06M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |